ZTALMY

Trials studying ZTALMY

• phase3Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Oldnot yet recruitingn=20
• phase3Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsyterminatedn=117
• phase3Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsycompletedn=129
• phase3Randomized Therapy In Status Epilepticuscompletedn=100
• phase2Open-label Extension to Protocol 1042-0500terminatedn=54
• phase3To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)withdrawn
• phase2Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)withdrawn
• —Ganaxolone Expanded Access Program Compassionate Useno longer available